Bruker Corporation
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $1.21B | $1.02B | $816.1M |
| Jun 2022 | $1.17B | $970.5M | $723.0M |
| Sep 2022 | $1.14B | $937.0M | $626.2M |
| Dec 2022 | $1.20B | $1.11B | $645.5M |
| Mar 2023 | $1.11B | $1.18B | $597.9M |
| Jun 2023 | $1.12B | $1.23B | $574.8M |
| Sep 2023 | $1.10B | $1.21B | $363.6M |
| Dec 2023 | $1.16B | $1.38B | $488.3M |
| Mar 2024 | $1.36B | $1.42B | $340.1M |
| Jun 2024 | $2.13B | $1.79B | $169.7M |
| Sep 2024 | $2.26B | $1.81B | $148.1M |
| Dec 2024 | $2.06B | $1.78B | $183.4M |
| Mar 2025 | $2.08B | $1.83B | $184.2M |
| Jun 2025 | $2.38B | $1.82B | $92.0M |
| Sep 2025 | $1.98B | $2.43B | $293.1M |
| Dec 2025 | $1.85B | $2.46B | $298.8M |
| Mar 2026 | $1.66B | $2.47B | $133.4M |
| Jun 2026 | $1.81B | $2.40B | $184.9M |